Adverse Biology in Adenocarcinoma of the Esophagus and Esophagogastric Junction Impacts Survival and Response to Neoadjuvant Therapy Independent of Anatomic Subtype-Reference-Cited by-同舟云学术

Adverse Biology in Adenocarcinoma of the Esophagus and Esophagogastric Junction Impacts Survival and Response to Neoadjuvant Therapy Independent of Anatomic Subtype

Published:2020-08-21 Issue:5 Volume:272 Page:814-819
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Donlon Noel E.,Elliott Jessie A.,Donohoe Claire L.,Murphy Conor F.,Nugent Tim,Moran Brendan,King Sinead,Ravi Narayanasamy,Reynolds John V.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference35 articles.

1. Cardia cancer: attempt at a therapeutically relevant classification;Siewert;Chirurg,1987

2. Classification of adenocarcinoma of the oesophagogastric junction;Siewert;Br J Surg,1998

3. Adenocarcinoma of the esophagogastric junction; results of surgical therapy based on anatomical/topographic classification of 1,002 consecutive patients;Siewert;Ann Surg,2000

4. Esophagogastric junction adenocarcinomas: Individualization of resection with special considerations for Siewert Type II, and Nishi Types EG, E=G, and GE cancers;Hölscher;Gastric Cancer,2020

5. Worldwide trends in surgical techniques in the treatment of esophageal and gastroesophageal junction cancer;Haverkamp;Dis Esophagus,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of early oesophageal cancer: An overview;World Journal of Gastrointestinal Surgery;2024-05-27

2. Histological prognosticators in neoadjuvant naive oesophageal cancer patients;Langenbeck's Archives of Surgery;2023-05-09

3. Integrative proteomic characterization of adenocarcinoma of esophagogastric junction;Nature Communications;2023-02-11

4. Endoscopic Management of Early Esophageal Cancer;Esophageal Cancer;2023

5. Nutrient deprivation and hypoxia alter T cell immune checkpoint expression: potential impact for immunotherapy;Journal of Cancer Research and Clinical Oncology;2022-11-29